TickerFacts.

Dexcom Inc (DXCM): Net Income

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2020-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$836.30M
Year ended 2025-12-31
$999.70M
Trailing 12 months to 2026-06-30
+34.8%
3-year compound annual growth
+8.8%
5-year compound annual growth
2009-12-31: -$53.52M2010-12-31: -$55.20M2011-12-31: -$44.70M2012-12-31: -$54.50M2013-12-31: -$29.80M2014-12-31: -$22.40M2015-12-31: -$57.60M2016-12-31: -$65.60M2017-12-31: -$50.20M2018-12-31: -$127.10M2019-12-31: $101.10M2020-12-31: $549.70M2021-12-31: $216.90M2022-12-31: $341.20M2023-12-31: $541.50M2024-12-31: $576.20M2025-12-31: $836.30M$836.30M
2009-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31$836.30M+45.1%2026-02-12, From 2025-01-01
2024-12-31$576.20M+6.4%2026-02-12, From 2024-01-01
2023-12-31$541.50M+58.7%2026-02-12, From 2023-01-01
2022-12-31$341.20M+57.3%2025-02-18, From 2022-01-01
2021-12-31$216.90M-60.5%2024-02-08, From 2021-01-01
2020-12-31$549.70Mn/c2023-02-09, From 2020-01-01
2019-12-31$101.10Mn/m2022-02-14, From 2019-01-01
2018-12-31-$127.10Mn/m2021-02-11, From 2018-01-01
2017-12-31-$50.20Mn/m2020-02-13, From 2017-01-01
2016-12-31-$65.60Mn/m2019-02-21, From 2016-01-01
2015-12-31-$57.60Mn/m2018-02-27, From 2015-01-01
2014-12-31-$22.40Mn/m2017-02-28, From 2014-01-01
2013-12-31-$29.80Mn/m2016-02-23, From 2013-01-01
2012-12-31-$54.50Mn/m2015-02-25, From 2012-01-01
2011-12-31-$44.70Mn/m2014-02-20, From 2011-01-01
2010-12-31-$55.20Mn/m2013-02-21, From 2010-01-01
2009-12-31-$53.52Mn/a2012-02-23, From 2009-01-01

Net Income at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Dexcom Inc (DXCM)2025-12-31$836.30M+45.1%
ResMed Inc (RMD)2026-06-30$1.52B+8.8%
MiniMed Group, Inc. (MMED)2026-04-24-$333.00Mn/m
West Pharmaceutical Services Inc (WST)2025-12-31$493.70M+0.2%
Globus Medical Inc (GMED)2025-12-31$537.87M+422.3%
Insulet Corp (PODD)2025-12-31$247.10M-40.9%
Solventum Corp (SOLV)2025-12-31$1.56B+224.8%
ICU Medical Inc (ICUI)2025-12-31$732.0Kn/m
Teleflex Inc (TFX)2025-12-31-$905.64Mn/m

Compare DXCM, RMD, MMED, WST side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗